197 related articles for article (PubMed ID: 33332878)
21. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
[TBL] [Abstract][Full Text] [Related]
22. Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison.
Gulea C; Zakeri R; Alderman V; Morgan A; Ross J; Quint JK
Respir Res; 2021 Feb; 22(1):64. PubMed ID: 33622362
[TBL] [Abstract][Full Text] [Related]
23. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
24. Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis.
van Gestel YR; Hoeks SE; Sin DD; Welten GM; Schouten O; Witteveen HJ; Simsek C; Stam H; Mertens FW; Bax JJ; van Domburg RT; Poldermans D
Am J Respir Crit Care Med; 2008 Oct; 178(7):695-700. PubMed ID: 18565952
[TBL] [Abstract][Full Text] [Related]
25. Use of cardioselective β-blockers in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized, placebo-controlled, blinded trials.
Ni Y; Shi G; Wan H
J Int Med Res; 2012; 40(6):2051-65. PubMed ID: 23321161
[TBL] [Abstract][Full Text] [Related]
26. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
[TBL] [Abstract][Full Text] [Related]
27. Beta-Blockers in COPD: A Methodological Review of the Observational Studies.
Suissa S; Ernst P
COPD; 2018 Oct; 15(5):520-525. PubMed ID: 30822238
[TBL] [Abstract][Full Text] [Related]
28. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
[TBL] [Abstract][Full Text] [Related]
29. Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis.
Yang YL; Xiang ZJ; Yang JH; Wang WJ; Xu ZC; Xiang RL
Eur Heart J; 2020 Dec; 41(46):4415-4422. PubMed ID: 33211823
[TBL] [Abstract][Full Text] [Related]
30. β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study.
Su TH; Chang SH; Kuo CF; Liu PH; Chan YL
PLoS One; 2019; 14(3):e0213187. PubMed ID: 30835781
[TBL] [Abstract][Full Text] [Related]
31. Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease.
Wade C; Wells JM
Expert Rev Respir Med; 2020 Jul; 14(7):671-678. PubMed ID: 32250198
[TBL] [Abstract][Full Text] [Related]
32. β-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT.
Dransfield MT; McAllister DA; Anderson JA; Brook RD; Calverley PMA; Celli BR; Crim C; Gallot N; Martinez FJ; Scanlon PD; Yates J; Vestbo J; Newby DE;
Ann Am Thorac Soc; 2018 May; 15(5):608-614. PubMed ID: 29406772
[TBL] [Abstract][Full Text] [Related]
33. Beta-blockers in COPD: A systematic review based on recent research.
Li XF; Mao YM
Life Sci; 2020 Jul; 252():117649. PubMed ID: 32275936
[TBL] [Abstract][Full Text] [Related]
34. Role of beta-blockers in patients with COPD: current perspective.
Malerba M; Montuschi P; Radaeli A; Pirisi M
Drug Discov Today; 2015 Jan; 20(1):129-35. PubMed ID: 25238736
[TBL] [Abstract][Full Text] [Related]
35. [Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease].
Karoli NA; Rebrov AP
Kardiologiia; 2021 Oct; 61(10):89-98. PubMed ID: 34763643
[TBL] [Abstract][Full Text] [Related]
36. [Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatment].
Rasmussen DB; Lange P; Jensen MT
Ugeskr Laeger; 2015 Sep; 177(38):V02150184. PubMed ID: 26376419
[TBL] [Abstract][Full Text] [Related]
37. Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.
Staszewsky L; Cortesi L; Tettamanti M; Dal Bo GA; Fortino I; Bortolotti A; Merlino L; Latini R; Roncaglioni MC; Baviera M
Eur J Heart Fail; 2016 Jul; 18(7):840-8. PubMed ID: 27098360
[TBL] [Abstract][Full Text] [Related]
38. Cardioselective beta-blockers for reversible airway disease.
Salpeter S; Ormiston T; Salpeter E
Cochrane Database Syst Rev; 2002; (1):CD002992. PubMed ID: 11869646
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.
Canepa M; Franssen FME; Olschewski H; Lainscak M; Böhm M; Tavazzi L; Rosenkranz S
JACC Heart Fail; 2019 Oct; 7(10):823-833. PubMed ID: 31521680
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.
Petta V; Perlikos F; Loukides S; Bakakos P; Chalkias A; Iacovidou N; Xanthos T; Tsekoura D; Hillas G
Heart Fail Rev; 2017 Nov; 22(6):753-763. PubMed ID: 28840400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
